Login to Your Account



Cubist Resolves Lawsuit with Teva for Cubicin

By Catherine Shaffer


Wednesday, April 6, 2011
Cubist Pharmaceuticals Inc. has settled its lawsuit with Teva Pharmaceutical Industries Ltd. and will soon see less money going to litigation and more going to innovation. The lawsuit, filed in 2009 by Cubist, alleged that Jerusalem-based Teva had infringed on Cubist's patent for Cubicin (daptomycin for injection) by filing for FDA approval of a generic version of Cubicin.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription